Who continues to stock oral artemisinin monotherapy? Results of a provider survey in Myanmar

BACKGROUND: Artemisinin-based combination therapy (ACT) is a key strategy for global malaria elimination efforts. However, the development of artemisinin-resistant malaria parasites threatens progress and continued usage of oral artemisinin monotherapies (AMT) predisposes the selection of drug resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Thein, Si Thu, Sudhinaraset, May, Khin, Hnin Su Su, McFarland, Willi, Aung, Tin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918101/
https://www.ncbi.nlm.nih.gov/pubmed/27333781
http://dx.doi.org/10.1186/s12936-016-1392-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918101/
https://www.ncbi.nlm.nih.gov/pubmed/27333781
http://dx.doi.org/10.1186/s12936-016-1392-5

Ejemplares similares